Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Advances in Mathematics Research. Volume 23
$250.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.Heaven on My Mind: Using the Harvard Grant Study of Adult Development to Explore the Value of the Prospection of Life after Death
02.A World Elegy: Perspectives on Global Affairs
03.The Ghost of Achilles
04.Suicide: A Global View on Suicidal Ideation among Adolescents
05.Leadership: Promoting Leadership and Intrapersonal Development in University Students
06.Psychosocial Needs: Success in Life and Career Planning
07.Cardiotoxicity of Chemotherapeutic Agents
08.Central Regulation of Growth: Morphological and Functional Considerations
09.Macedonia: Social, Political and Economic Issues
10.Snails: Biodiversity, Biology and Behavioral Insights
11.Ecological and Biogeochemical Cycling in Impacted Polar Ecosystems
12.Control and Prevention of American Foulbrood in Honey Bees

Nova Science Publishers
© Copyright 2004 - 2017

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266